Sanofi, Dr. Reddy’s, Teva Recall Ranitidine Products Due to NDMA Impurity
By
Several companies, Sanofi, Dr. Reddy’s Laboratories, and Teva Pharmaceutical, have initiated voluntary recalls of ranitidine products, an anti-acid, due to possible contamination with a nitrosamine impurity, N-nitrosodimethylamine (NDMA). Sanofi says…
MilliporeSigma Acoustic Technology for Cell Therapy Mfg; Sekisui Invests $1.9 M in Biomfg
By
The latest news from CDMOs, CMOs, and suppliers featuring news from MilliporeSigma, Sekisui Diagnostics, TriPharm Services, ACG Inspection, and Bormioli Pharma. Biologics Manufacturing MilliporeSigma To Use Acoustic Technology for Cell…
Takeda To Divest Select OTC and Rx Products in Emerging Markets for $200 Million-Plus
By
Takeda Pharmaceutical has agreed to divest to Acino, a Zurich-based pharmaceutical company, a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of countries in the Near…